Crucial Role of Aspartic Acid at Position 265 in the CH2 Domain for Murine IgG2a and IgG2b Fc-Associated Effector Functions

被引:81
作者
Baudino, Lucie [1 ]
Shinohara, Yasuro [2 ]
Nimmerjahn, Falk [3 ]
Furukawa, Jun-Ichi [2 ]
Nakata, Munehiro [4 ]
Martinez-Soria, Eduardo [1 ]
Petry, Franz [5 ]
Ravetch, Jeffery V. [6 ]
Nishimura, Shin-Ichiro [2 ]
Izui, Shozo [1 ]
机构
[1] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland
[2] Hokkaido Univ, Grad Sch Adv Life Sci, Lab Adv Chem Biol, Sapporo, Hokkaido, Japan
[3] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Lab Expt Immunol & Immunotherapy, Erlangen, Germany
[4] Tokai Univ, Dept Appl Biochem, Kanagawa 2591100, Japan
[5] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Mainz, Germany
[6] Rockefeller Univ, New York, NY 10021 USA
关键词
D O I
10.4049/jimmunol.181.9.6664
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Replacement of aspartic acid by alanine at position 265 (D265A) in mouse IgG1 results in a complete loss of interaction between this isotype and low-affinity IgG Fc receptors (Fc gamma RIIB and Fc gamma RIII). However, it has not yet been defined whether the D265A substitution could exhibit similar effects on the interaction with two other Fc gamma R (Fc gamma RI and Fc gamma RIV) and on the activation of complement. To address this question, 34-3C anti-RBC IgG2a and IgG2b switch variants bearing the D265A mutation were generated, and their effector functions and in vivo pathogenicity were compared with those of the respective wild-type Abs. The introduction of the D265A mutation almost completely abolished the binding of 34-3C IgG2a and IgG2b to all four classes of Fc gamma R and the activation of complement. Consequently, these mutants were hardly pathogenic. Although oligosaccharide side chains of these mutants were found to contain higher levels of sialic acids than those of wild-type Abs, the analysis of enzymatically desialylated D265A variants ruled out the possibility that very poor Fc-associated effector functions of the D265A mutants were due to an increased level of the mutant Fc sialylation. Thus, our results demonstrate that aspartic acid at position 265 is a residue critically implicated in triggering the Fc-associated effector functions of IgG, probably by defining a crucial three-dimensional structure of the Fc region. The Journal of Immunology, 2008, 181: 6664-6669.
引用
收藏
页码:6664 / 6669
页数:6
相关论文
共 30 条
[11]   Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans [J].
Kita, Yoko ;
Miura, Yoshiaki ;
Furukawa, Jun-ichi ;
Nakano, Mika ;
Shinohara, Yasuro ;
Ohno, Masahiro ;
Takimoto, Akio ;
Nishimura, Shin-lchiro .
MOLECULAR & CELLULAR PROTEOMICS, 2007, 6 (08) :1437-1445
[12]  
KLAUS GGB, 1979, IMMUNOLOGY, V38, P687
[13]   Level of galactosylation determines cryoglobulin activity of murine IgG3 monoclonal rheumatoid factor [J].
Kuroki, A ;
Kuroda, Y ;
Kikuchi, S ;
Lajaunias, F ;
Fulpius, T ;
Pastore, Y ;
Fossati-Jimack, L ;
Reininger, L ;
Toda, T ;
Nakata, M ;
Kojima, N ;
Mizuochi, T ;
Izui, S .
BLOOD, 2002, 99 (08) :2922-2928
[14]  
Lund J, 1996, J IMMUNOL, V157, P4963
[15]   Rapid and simple solid-phase esterification of sialic acid residues for quantitative glycomics by mass spectrometry [J].
Miura, Yoshiaki ;
Shinohara, Yasuro ;
Furukawa, Jun-ichi ;
Nagahori, Noriko ;
Nishimurara, Shin-ichiro .
CHEMISTRY-A EUROPEAN JOURNAL, 2007, 13 (17) :4797-4804
[16]  
MIZUOCHI T, 1990, J IMMUNOL, V145, P1794
[17]   Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF [J].
Molina, H ;
Miwa, T ;
Zhou, L ;
Hilliard, B ;
Mastellos, D ;
Maldonado, MA ;
Lambris, JD ;
Song, WC .
BLOOD, 2002, 100 (13) :4544-4549
[18]   Fcγ receptors:: Old friends and new family members [J].
Nimmerjahn, F ;
Ravetch, JV .
IMMUNITY, 2006, 24 (01) :19-28
[19]   FcγRIV:: A novel FcR with distinct IgG subclass specificity [J].
Nimmerjahn, F ;
Bruhns, P ;
Horiuchi, K ;
Ravetch, JV .
IMMUNITY, 2005, 23 (01) :41-51
[20]   The antiinflammatory activity of IgG: the intravenous IgG paradox [J].
Nimmerjahn, Falk ;
Ravetch, Jeffrey V. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (01) :11-15